— Know what they know.
Not Investment Advice

STSN OTC

Stemsation International, Inc.
1W: +22.7% 1M: -3.3% 3M: +228.3% YTD: +480.0% 1Y: +185.2% 3Y: +45.0% 5Y: -33.6%
$0.02
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 47 · $1.5M mcap · 30M float · 1.04% daily turnover · Short 78% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$1.5M
52W Range0.0015-0.0205
Volume35,000
Avg Volume312,434
Beta0.93
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEORay C. Carter Jr.
Employees4
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2008-01-31
1537 NW 65th Avenue
Plantation, FL 33313
US
561-245-7454
About Stemsation International, Inc.

StemSation International, Inc., headquartered in Boca Raton, Florida, specializes in the development, manufacture, and distribution of natural wellness products. These offerings are specifically designed to bolster the human body's stem cell and endocannabinoid systems. Among its key products is StemRCM, a nutritional supplement created to enhance stem cells' natural capacity to mend, rejuvenate, and revitalize bodily tissues and organs. This is achieved by promoting healthy stem cell liberation, transport, and targeting within the system. The company markets its goods directly to consumers through a network of independent health advocates.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms